The Cohorts · Quarterly vintage
Inception 2024-04-01 · 2.3 years held
Q2 2024 · Top 5.
On 2024-04-01, these 5 businesses were the 5most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q2 2024 · Top 5 · since inception
+58.7%
CAGR 21.8% annualised
S&P 500 · since inception
+51.7%
CAGR 19.5% annualised
Spread
+7.0%
This cohort has beaten the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 20.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | JPM | $188.77 | $5,661.57 | +2787.4% | $357.52 | +89.4% | +17.9% | Read → |
| 2 | BAC | $35.63 | $368.47 | +864.1% | $62.90 | +76.6% | +15.3% | Read → |
| 3 | CAT | $352.15 | $2,013.41 | +529.7% | $876.54 | +148.9% | +29.8% | Read → |
| 4 | OXY | $63.55 | $399.68 | +528.9% | $55.09 | -13.3% | -2.7% | Read → |
| 5 | LOW | $237.34 | $1,213.01 | +446.2% | $218.08 | -8.1% | -1.6% | Read → |
Biggest contributors
Where the cohort earned its keep.
- CAT · $352.15 → $876.54+148.9%
- JPM · $188.77 → $357.52+89.4%
- BAC · $35.63 → $62.90+76.6%
Biggest detractors
Where the protocol got it wrong.
- OXY · $63.55 → $55.09-13.3%
- LOW · $237.34 → $218.08-8.1%